Results 131 to 140 of about 825 (170)
Some of the next articles are maybe not open access.
Effect of Blonanserin on the Proliferation and Migration of Glioblastoma Cells
Die Pharmazie, 2023Glioblastoma is a highly malignant and invasive brain tumor, and there is an urgent need to establish a treatment option that prevents its growth and metastasis. Blonanserin is an antipsychotic drug widely used in the treatment of schizophrenia. It has recently been reported to inhibit the growth of breast cancer cells.
Tsuchiya, N. +4 more
openaire +2 more sources
Journal of Clinical Psychopharmacology, 2018
Abstract Purpose/Background Blonanserin is a novel antipsychotic drug approved for the treatment of schizophrenia in East Asia. The main objective of the present study was to investigate the effect of alcohol on the pharmacokinetic properties of blonanserin and its metabolite N-deethyl blonanserin in healthy Chinese ...
Shuhua, Deng +11 more
openaire +2 more sources
Abstract Purpose/Background Blonanserin is a novel antipsychotic drug approved for the treatment of schizophrenia in East Asia. The main objective of the present study was to investigate the effect of alcohol on the pharmacokinetic properties of blonanserin and its metabolite N-deethyl blonanserin in healthy Chinese ...
Shuhua, Deng +11 more
openaire +2 more sources
Blonanserin HCl salt and its monohydrate
CrystEngComm, 2012X-Ray crystal structure of the hydrochloride salt of an antipsychotic drug blonanserin (BLN) and characterization of a high temperature polymorph are reported. The crystal structure of BLN HCl monohydrate was determined. All new solid-state forms are characterized by X-ray diffraction, thermal microscopy, ss-NMR, and FT-IR spectroscopy.
D. Maddileti +3 more
openaire +1 more source
Neuroleptic Malignant Syndrome Induced by Blonanserin
Journal of Neuropsychiatry, 2011Case Report A 30-year-old woman with a diagnosis of mental retardation and with profound intellectual impairment (IQ 45) was admitted to a psychiatric hospital for the first time because of insomnia, psychomotor agitation, monologue, and persecutory delusions.
Keiko Ohoyama +7 more
openaire +1 more source
[Blonanserin in the treatment of schizophrenia].
Nihon rinsho. Japanese journal of clinical medicine, 2013Blonanserin was developed in Japan in 2008 as an antipsychotic drug. It has high affinity for dopamine D2/3 and serotonin 5-HT2A receptors, but shows low affinity for adrenergic alpha1, histamine H1, and muscarinic M1 receptors. Several short-term double-blind trials demonstrated that blonanserin was well tolerated and had equal efficacy to haloperidol
Tomomi, Tenjin, Seiya, Miyamoto
openaire +1 more source
Blonanserin patch for schizophrenia
Schizophrenia Research, 2020Chittaranjan, Andrade +3 more
openaire +2 more sources

